Thermo Fisher Scientific to Present at 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021

Thermo Fisher Scientific (NYSE: TMO) announced that CEO Marc N. Casper will present at the 39th Annual J.P.

Rhea-AI Summary

Thermo Fisher Scientific (NYSE: TMO) announced that CEO Marc N. Casper will present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 3:40 p.m. (EDT). The presentation will cover the company's insights on the COVID-19 pandemic and future financial outlook. The webcast can be accessed through the Investors section of the company's website. Thermo Fisher has an annual revenue exceeding $25 billion and employs over 75,000 people globally.

Argus Session date unavailable

+1.57% session move Open Argus

Details

News Market Reaction – TMO

The recorded move for TMO in the trading session of this news was +1.57%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass., Jan. 6, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 39^th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021, at 3:40 p.m. (EDT).  Among other topics, Mr. Casper will provide the company's current perspective on the impact of the COVID-19 pandemic and expectations for future financial performance.

You can access the webcast of the presentation via the Investors section of our website, www.thermofisher.com.

About Thermo Fisher Scientific 

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.

Media Contact Information:
Ron O'Brien
Phone: 781-622-1242
E-mail: ron.obrien@thermofisher.com  
Website: www.thermofisher.com

Investor Contact Information:
Ken Apicerno
Phone: 781-622-1294
E-mail: ken.apicerno@thermofisher.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/thermo-fisher-scientific-to-present-at-39th-annual-jp-morgan-healthcare-conference-on-january-11-2021-301201749.html

SOURCE Thermo Fisher Scientific

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Thermo Fisher Scientific present at the J.P. Morgan Healthcare Conference?

Thermo Fisher Scientific will present at the J.P. Morgan Healthcare Conference on January 11, 2021, at 3:40 p.m. (EDT).

Who is presenting for Thermo Fisher Scientific at the conference?

CEO Marc N. Casper will present for Thermo Fisher Scientific at the conference.

What topics will Thermo Fisher Scientific discuss at the J.P. Morgan Healthcare Conference?

The discussion will focus on the impact of the COVID-19 pandemic and the company's future financial performance.

How can I access the Thermo Fisher Scientific presentation?

You can access the presentation via the Investors section of Thermo Fisher Scientific's website.

What is the annual revenue of Thermo Fisher Scientific?

Thermo Fisher Scientific has an annual revenue exceeding $25 billion.